2016
DOI: 10.5812/ijem.37792
|View full text |Cite
|
Sign up to set email alerts
|

Avoiding Misdiagnosis Due to Antibody Interference with Serum Free Thyroxin

Abstract: IntroductionInterfering antibodies are capable of causing potentially misleading results in automated thyroid hormone immunoassays.Case PresentationWe report the case of a 46- year-old female patient with autoimmune hypothyroidism in chronic replacement treatment with levothyroxine who was presented 8 years after diagnosis with a thyroid function test showing an increased level of TSH and a very high level of FT4. Interference in the laboratory serum free thyroxin (FT4) test was suspected, due to the lack of s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0
3

Year Published

2017
2017
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 20 publications
0
3
0
3
Order By: Relevance
“…In vivo, the free thyroid hormone Ab seems to behave like another endogenous binding protein. The frequency of anti-T4 and anti-T3 autoAbs specifically relates to autoimmune thyroid disorders such as Hashimoto thyroiditis and other autoimmune diseases (e.g., lupus erythematosus, vitiligo) [80,[83][84][85][86]. These autoAbs can be induced by interferon-α therapy or can be transient and associated with Epstein-Barr-virus infection [87,88].…”
Section: Free Thyroid Hormonesmentioning
confidence: 99%
“…In vivo, the free thyroid hormone Ab seems to behave like another endogenous binding protein. The frequency of anti-T4 and anti-T3 autoAbs specifically relates to autoimmune thyroid disorders such as Hashimoto thyroiditis and other autoimmune diseases (e.g., lupus erythematosus, vitiligo) [80,[83][84][85][86]. These autoAbs can be induced by interferon-α therapy or can be transient and associated with Epstein-Barr-virus infection [87,88].…”
Section: Free Thyroid Hormonesmentioning
confidence: 99%
“…To demonstrate the presence of an assay artifact, we first reassessed TFTs with a one-step assay (electrochemiluminescence immunoassay, Roche Elecsys, Mannheim, Germany) and with a two-step method (Wallac DELFIA Perkin-Elmer) both confirming the biochemical feature of central hyperthyroidism (Table 1). As proband’s serum had been reported to us to potentially contain anti-T4 and anti-T3 antibodies on a radioimmunoprecipitation technique [10], we performed a polyethylene glycol (PEG) precipitation test, described by Beato-Víbora and Alejo-González [11], to exclude interference by circulating immunoglobulins on TFTs.…”
Section: Case Presentationmentioning
confidence: 99%
“…Лечение гипотиреоза на фоне АИТ сводится в основном к использованию заместительной тера-пии тиреоидными гормонами (ТГ) в случае его мани-фестации [4,7]. Однако по современным представле-ниям ТГ отводят роль антигенов в патогенезе ауто-иммунного воспаления ЩЖ [5,8,9], из чего следует, что заместительная терапия в этих случаях может поддерживать персистенцию аутоиммунного про-цесса, в том числе при IgG4-обусловленном тирео-идите, когда наиболее важное значение приобретает взаимодействие В-и Т-клеток с клетками врожден-ного иммунитета [1,4,5,10]. АИT относится к за-болеваниям, при котором аутоиммунное воспаление опосредовано прежде всего Т-клетками, а точная роль В-клеток в его патогенезе также остается до сих пор неясной [2][3][4].…”
Section: актуальностьunclassified